◆英語タイトル:Kineta Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013963
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月22日
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Kineta Inc (Kineta) is a biotech company that develops novel immuno-therapies. The company offers small-molecule compounds that target RIG-I-like receptor pathways and intracellular IRF3-inducing pathways for applications in cancer. Its KCP-400 is a novel non-opioid therapy for the treatment of chronic pain. Kineta antiviral drugs such as LHF-535 for arena viruses including Lassa fever and innate immune antivirals. The company also develops pipeline products for the treatment of various therapeutic areas including respiratory syncytial virus, influenza, corona viruses, chronic pain, dengue virus, ebola, west nile virus, hepatitis b and c, and others. It collaborates with academia, government and non-governmental organizations. Kineta is headquartered in Seattle, Washington, the US.
Kineta Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Kineta Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Kineta Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Kineta Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Kineta Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Kineta Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Kineta Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Kineta Four Acquires Lassa Fever Assets from SIGA Technologies 11
Venture Financing 12
Kineta Raises Funds in Financing 12
Kineta Raises USD24.4 Million in Venture Financing 13
Kineta Raises USD5 Million in Venture Financing 14
Kineta Raises Funds through Venture Financing 15
Kineta Raises USD0.25 Million in Venture Financing 16
Kineta Raises USD1.8 Million in Venture Financing 17
Kineta Two Raises USD0.067 Million in Venture Financing 18
Kineta Raises USD1.6 Million in Venture Financing 19
Kineta Raises USD1.6 Million in Venture Financing 20
KPI Therapeutics Raises USD1.6 Million in Venture Financing 21
Kineta Raises Funds Through Venture Financing 22
Kineta Two Raises US$3 Million In Venture Financing 23
Private Equity 24
Hydra Invests In Kineta, Biotech Company 24
Partnerships 25
Kineta Enters into Contract with US Army Institute of Surgical Research 25
Kineta, KPI Therapeutics Enter into Partnership with UW Medicine and University of Washington 26
Kineta And RLB Enter Into Joint Venture Agreement To Form Kineta RLB 27
Licensing Agreements 28
Kineta Enters Into Licensing Agreement With University of Utah Research Foundation 28
Acquisition 29
RLB Acquires Minority Stake In Kineta 29
Kineta Inc – Key Competitors 30
Kineta Inc – Key Employees 31
Kineta Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Government and Public Interest 33
Jul 12, 2016: Kineta Secures NIAID Funding to Expand Testing of Immune Modulators 33
Product News 34
May 16, 2016: Kineta Presents Promising New Vaccine Adjuvant Data at American Association of Immunologists Annual Meeting 34
Clinical Trials 35
Feb 22, 2017: KCP-400 Relieves Chronic Pain and Demonstrates Disease Modifying Effects 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Tables
Kineta Inc, Pharmaceuticals & Healthcare, Key Facts 2
Kineta Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Kineta Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Kineta Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Kineta Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Kineta Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Kineta Four Acquires Lassa Fever Assets from SIGA Technologies 11
Kineta Raises Funds in Financing 12
Kineta Raises USD24.4 Million in Venture Financing 13
Kineta Raises USD5 Million in Venture Financing 14
Kineta Raises Funds through Venture Financing 15
Kineta Raises USD0.25 Million in Venture Financing 16
Kineta Raises USD1.8 Million in Venture Financing 17
Kineta Two Raises USD0.067 Million in Venture Financing 18
Kineta Raises USD1.6 Million in Venture Financing 19
Kineta Raises USD1.6 Million in Venture Financing 20
KPI Therapeutics Raises USD1.6 Million in Venture Financing 21
Kineta Raises Funds Through Venture Financing 22
Kineta Two Raises US$3 Million In Venture Financing 23
Hydra Invests In Kineta, Biotech Company 24
Kineta Enters into Contract with US Army Institute of Surgical Research 25
Kineta, KPI Therapeutics Enter into Partnership with UW Medicine and University of Washington 26
Kineta And RLB Enter Into Joint Venture Agreement To Form Kineta RLB 27
Kineta Enters Into Licensing Agreement With University of Utah Research Foundation 28
RLB Acquires Minority Stake In Kineta 29
Kineta Inc, Key Competitors 30
Kineta Inc, Key Employees 31
Kineta Inc, Subsidiaries 32